The U.S. Securities and Exchange Commission has frozen its approval of Nasdaq bitcoin index options and reopened the decision for review after a challenge from CME Group over regulatory jurisdiction.
SEC puts QBTC approval on hold
In May, the SEC conditionally approved Nasdaq PHLX to list cash-settled bitcoin index options under the ticker QBTC. CME objected in June, arguing that because bitcoin is treated as a commodity, options directly tied to its value should fall under the Commodity Futures Trading Commission rather than the SEC.
On July 29, the SEC accepted CME’s petition for review and temporarily stayed the earlier approval while it considers the matter. The agency also opened a public comment period, with submissions due by Aug. 24.
CME says the product belongs under CFTC oversight
CME’s position is straightforward: if bitcoin is a commodity, then options that directly reference its value should sit within the CFTC’s exclusive jurisdiction, not the SEC’s. The dispute puts an old question back in focus for crypto derivatives: which regulator should be in charge.
The decision could determine whether the product can launch
The outcome will shape whether QBTC can move ahead in its current form. If CME’s argument prevails, the SEC would not have authority to approve the product. Nasdaq would then either need to register as a CFTC-regulated futures or swap venue, or redesign the contract so it tracks a security such as a spot bitcoin ETF.
The dispute echoes recent fights over whether prediction markets and event contracts should be treated as securities, commodities, or gambling products. Crypto assets continue to cut across the traditional boundary between securities and commodities, leaving regulators to revisit where those lines should be drawn.